Psychedelics Investing GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer
Psychedelics Investing GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences
Psychedelics Investing GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.
Pharmaceutical Investing Greenstar Biosciences Signs Agreement to Acquire 100 Percent of Eleusian Biosciences Corp.
AMENDED FROM SOURCE - Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement
